InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: None

Wednesday, 03/06/2019 11:17:13 AM

Wednesday, March 06, 2019 11:17:13 AM

Post# of 108192
So, where are those "expected" multiple catalysts for this quarter?

PROGRAM ANTICIPATED MILESTONES TARGET

ADXS-HPV (axalimogene filolisbac)
•Announce planned Investigator Sponsored Trial in Head and Neck Cancer Q1 2019

ADXS-PSA
•Metastatic Prostate Ph1/2 Combination with pembrolizumab--Part B Monotherapy Combination Therapy Data (12-mo PFS and OS) Q1 2019

ADXS-NEO
•Data from initial clinical cohort (safety, immune response)Q1 2019

WISHLIST
FDA approves mod to SPA AIM2CERV and releases partial hold
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News